Olive leaf in cardiometabolic disease – key benefits and evidence gaps

Press/Media

Description

Blog post the current evidence, as well as gaps in the evidence, concerning the medicinal benefits of olive leaf extract in cardiometabolic diseases.

Subject

Olive leaf extract (OLE) shows promise as an intervention for modifying cardiometabolic risk factors. However additional clinical trial evidence is needed, and the lack of phytoequivalence of OLE products on the Australian market makes clinical extrapolation from previous research somewhat problematic.

Period31 Aug 2022

Media contributions

1

Media contributions

  • TitleOlive leaf in cardiometabolic disease – key benefits and evidence gaps
    Degree of recognitionInternational
    Media name/outletOlive Wellness Institute
    Media typeWeb
    Country/TerritoryAustralia
    Date31/08/22
    DescriptionOlive leaf extract (OLE) shows promise as an intervention for modifying cardiometabolic risk factors. However additional clinical trial evidence is needed, and the lack of phytoequivalence of OLE products on the Australian market makes clinical extrapolation from previous research somewhat problematic.
    PersonsMatthew J. Leach, Ian Breakspear